Centessa Pharmaceuticals plc (CNTA) rose 17.65% to $26.52, up $3.98, after announcing it has priced an underwritten public offering of 11.63 million American Depositary Shares - ADSs at $21.50 per ADS, raising approximately $250 million in gross proceeds.
The company granted underwriters a 30-day option to purchase up to 1.74 million additional ADSs at the offering price minus underwriting discounts and commissions.
On the day of the announcement, CNTA experienced unusually heavy trading volume as investors reacted to the deal. The stock's 52-week range is $9.60 - $26.52.
For comments and feedback contact: editorial@rttnews.com
Business News
December 26, 2025 08:42 ET Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.